Horizon Therapeutics (HZNP) all U.S. Lobbying: all historical lobbying contracts, government bills & agencies, and critical issues lobbied on.

$99.95

Discover Horizon Therapeutics’s lobbying activities with our comprehensive dataset, offering insights on spending, bills, and issues from 1999-present. Analyze data by company, lobbyist, issue, and more through our intelligently crafted data design. Dataset updated weekly.

Description

Using our intelligently designed and intuitive dataset, you can quickly understand how Horizon Therapeutics (HZNP) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.

Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.

For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.

Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.

Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:

1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.

2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.

3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).

4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.

5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).

6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).

7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).

Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].

Frequently Asked Questions

What is Horizon Therapeutics (HZNP) lobbying for?

Summary of Horizon Therapeutics’ Lobbying Data:

– Horizon Therapeutics hired several lobbying firms, including Ricchetti Incorporated, The Mcmanus Group, and Gray Global Advisors.
– They lobbied on general issues such as taxation/Internal Revenue Code, pharmacy, Medicare/Medicaid, and health issues.
– Horizon Therapeutics also lobbied on specific issues such as Medicare and Medicaid reimbursement, drug pricing and reimbursement, access and reimbursement in Medicare Part D and Part B, and issues related to orphan drugs and the value of innovative medicines.
– They lobbied with various government agencies, including the House of Representatives, Department of Health & Human Services (HHS), Senate, Centers For Medicare and Medicaid Services (CMS), and Executive Office of the President (EOP).

One could infer that Horizon Therapeutics is lobbying on these issues to influence policies and regulations that could benefit their business interests, such as improving access and reimbursement for their drugs, supporting legislation that favors the pharmaceutical industry, and advocating for favorable tax policies. They may also be lobbying to protect their profits by opposing policies that could lower drug prices or increase competition in the market.

Subscribe To Our Newsletter

gain actionable insights from our alternative data

More to explore